"Receptors, Dopamine D2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES.
Descriptor ID |
D017448
|
MeSH Number(s) |
D12.776.543.750.670.300.400.500 D12.776.543.750.695.150.400.500 D12.776.543.750.720.330.400.500
|
Concept/Terms |
Receptors, Dopamine D2- Receptors, Dopamine D2
- Dopamine-D2 Receptor
- Dopamine D2 Receptor
- Receptor, Dopamine-D2
- Dopamine D2 Receptors
- D2 Receptors, Dopamine
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Dopamine D2".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Biogenic Amine [D12.776.543.750.670]
- Receptors, Catecholamine [D12.776.543.750.670.300]
- Receptors, Dopamine [D12.776.543.750.670.300.400]
- Receptors, Dopamine D2 [D12.776.543.750.670.300.400.500]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Catecholamine [D12.776.543.750.695.150]
- Receptors, Dopamine [D12.776.543.750.695.150.400]
- Receptors, Dopamine D2 [D12.776.543.750.695.150.400.500]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Catecholamine [D12.776.543.750.720.330]
- Receptors, Dopamine [D12.776.543.750.720.330.400]
- Receptors, Dopamine D2 [D12.776.543.750.720.330.400.500]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Dopamine D2".
This graph shows the total number of publications written about "Receptors, Dopamine D2" by people in this website by year, and whether "Receptors, Dopamine D2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1996 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2004 | 1 | 0 | 1 |
2006 | 2 | 0 | 2 |
2007 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Dopamine D2" by people in Profiles.
-
The role of dopamine pharmacotherapy and addiction-like behaviors in Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2020 08 30; 102:109942.
-
Pharmacological insights into impulsive-compulsive spectrum disorders associated with dopaminergic therapy. Eur J Neurosci. 2019 08; 50(3):2492-2502.
-
Common variants in DRD2 are associated with sleep duration: the CARe consortium. Hum Mol Genet. 2016 Jan 01; 25(1):167-79.
-
Dopamine receptors and the persistent neurovascular dysregulation induced by methamphetamine self-administration in rats. J Pharmacol Exp Ther. 2014 Nov; 351(2):432-9.
-
Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2008 Nov; 33(12):2791-800.
-
Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride. Biol Psychiatry. 2008 Jan 15; 63(2):241-4.
-
Dopamine D(2) receptor modulation of K(+) channel activity regulates excitability of nucleus accumbens neurons at different membrane potentials. J Neurophysiol. 2006 Nov; 96(5):2217-28.
-
Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans. Neuropsychopharmacology. 2006 May; 31(5):1016-26.
-
Dopamine D2 receptor-activated Ca2+ signaling modulates voltage-sensitive sodium currents in rat nucleus accumbens neurons. J Neurophysiol. 2005 Mar; 93(3):1406-17.
-
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals. Proc Natl Acad Sci U S A. 2002 Oct 15; 99(21):13873-7.